CME Group Inc. $CME Shares Sold by J. Safra Sarasin Holding AG

Key Points

• J. Safra Sarasin Holding AG reduced its stake in CME Group Inc. by 0.6% in the second quarter, selling 2,828 shares, which leaves it with approximately 487,942 shares valued at approximately $134.5 million.
• Insiders have sold a total of 13,043 shares of CME Group stock worth about $3.5 million over the last 90 days, indicating some movement in executive holdings.
• CME Group reported quarterly earnings of $2.96 per share, exceeding estimates, with revenue of $1.69 billion, marking a 10.4% year-over-year increase.

J. Safra Sarasin Holding AG lessened its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 0.6% in the second quarter, according to its most recent filing with the SEC. The firm owned 487,942 shares of the financial services provider's stock after selling 2,828 shares during the quarter. CME Group makes up approximately 2.3% of J. Safra Sarasin Holding AG's investment portfolio, making the stock its 5th largest holding. J. Safra Sarasin Holding AG owned approximately 0.14% of CME Group worth $134,487,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Heartland Bank & Trust Co acquired a new stake in shares of CME Group during the 1st quarter worth approximately $377,000. Catalyst Capital Advisors LLC boosted its stake in CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after purchasing an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. purchased a new position in shares of CME Group during the first quarter valued at approximately $367,000. Fulcrum Equity Management purchased a new position in shares of CME Group during the first quarter valued at approximately $258,000. Finally, AIA Group Ltd boosted its position in shares of CME Group by 17.8% during the first quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock valued at $4,416,000 after buying an additional 2,510 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the firm's stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company's stock, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider owned 9,508 shares of the company's stock, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,043 shares of company stock valued at $3,527,956 over the last 90 days. 0.30% of the stock is owned by insiders.

CME Group Trading Down 1.6%

Shares of CME opened at $265.84 on Thursday. CME Group Inc. has a fifty-two week low of $213.94 and a fifty-two week high of $290.79. The business has a 50-day moving average of $270.51 and a 200 day moving average of $271.09. The firm has a market cap of $95.80 billion, a P/E ratio of 25.73, a price-to-earnings-growth ratio of 4.90 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm posted $2.56 earnings per share. The company's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Analyst Ratings Changes

CME has been the topic of a number of analyst reports. Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. Oppenheimer boosted their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Morgan Stanley boosted their target price on CME Group from $303.00 to $312.00 and gave the stock an "overweight" rating in a research note on Wednesday. Barclays set a $298.00 target price on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Finally, Piper Sandler boosted their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Five research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $268.71.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.